about
Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approachesFitting the elementary rate constants of the P-gp transporter network in the hMDR1-MDCK confluent cell monolayer using a particle swarm algorithmRegulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis.Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primateInteraction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.Understanding and preventing drug-drug and drug-gene interactions.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesRecent patents on ophthalmic nanoformulations and therapeutic implicationsComplex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropionP-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study.Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry.Drug Interactions at the Human Placenta: What is the Evidence?Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1.Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.Drug-drug interactions involving membrane transporters in the human kidney.Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.Transporter-mediated uptake into cellular compartments.Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.Inhibition of flucloxacillin tubular renal secretion by piperacillinModulation of drug efflux by aloe materials: An In Vitro investigation across rat intestinal tissueSimultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primateDrug interactions at the blood-brain barrier: fact or fantasy?Substrate-dependent inhibition of human MATE1 by cationic ionic liquids.Drug transporters: gatekeepers controlling access of xenobiotics to the cellular interior.P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models.Overcoming multidrug resistance in human cancer cells by natural compoundsRenal transport of organic anions and cations.Suitability of digoxin as a P-glycoprotein probe: implications of other transporters on sensitivity and specificity.Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1.Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions.ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma.Effect of bifendate on the pharmacokinetics of talinolol in healthy subjects.Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII8-12.Potential pharmacokinetic effect of rifampicin on enrofloxacin in broilers: Roles of P-glycoprotein and BCRP induction by rifampicin.P-glycoprotein expression in Helicobacter pylori-positive patients: the influence of MDR1 C3435T polymorphism.
P2860
Q28487360-72228DD9-7F89-4709-ACCD-00DF22D18C78Q28743796-B5C04D88-9EF6-4E63-8227-7AC642305721Q33574623-206426DD-5020-4C2A-988E-66B78BC49D3DQ33673118-3AC0A71F-4C82-44CA-8BBD-3EAADFB1EDBEQ34094825-C5891CF7-2753-4092-85C4-50FC16ABCF59Q34298854-4F5F0610-847E-4787-8C84-6FAA74B1748CQ34415944-F1EFE678-52C9-424C-AADD-E289FC30E4E9Q34657381-6AFEC212-0E63-4B29-AF3D-152B34163496Q35043004-42654498-990D-455C-861F-BF3C4BACD477Q35776626-35595947-9834-4DD9-9A37-61DCE3DDA2F1Q35802617-9893BEC6-8721-4A5E-8870-15E4B9190244Q35913104-48E46365-9BE2-401C-8308-C88AEEF204D4Q36081992-E5D9617C-0071-480B-A0DA-72D55FB32F45Q36228911-B4E6A107-BF30-4E49-AD95-F77080599F84Q36306228-80E5975E-4C93-4E4D-86EF-AB2C0AAF6919Q36543091-C4C74C5C-02CB-497F-8F9C-70DDAD0A9A30Q36571957-EAF4DF9D-7A9A-472E-B086-135096AE0095Q36985076-70018296-403C-41CF-95FA-C016449C8C3AQ37027034-2B1B52CC-57D9-4852-9F95-5774A188BE0AQ37142437-BA0CBB8A-2919-43D0-BA83-7EF1D12221A1Q37233305-E054E4AC-5533-439C-9277-872DB1E26BBAQ37244471-9191C8AC-2B3E-4675-B36E-8F84DAA887EEQ37362486-4BD2CF35-CE96-41D7-AD82-C473FDA68779Q37422651-7C3B428D-CFF1-4A41-991E-E2DDB217B236Q37514340-8D069AF7-09CC-4979-91CB-164E647B8D9FQ37732337-AEA9B6B1-5E1A-4EE7-8396-7853992020FFQ37846234-2A18949E-D428-4257-8CAB-A983706CA9D1Q37954295-9C8066A3-CC1E-4AED-A6FD-D3AB6CAAD777Q38111725-A90D00B4-CBEE-4F6D-8D3C-4562CBBEF0AFQ38156114-3A3C44C1-A5A4-49EF-81D7-3921D6CBDDB1Q38715341-B9EC77B9-8F5D-4E21-914F-404B60B409B0Q38844650-12B4F712-5610-40E9-B6E3-B36731B7F480Q38844658-0C0B35F2-11B5-4341-9398-7DF62ABD8D65Q39447754-DBD5C547-5C90-4E8D-AEAB-8ED40E8A4CD3Q39773779-2BDAD841-D678-482C-A03D-F0EFD76AF166Q41813332-593D0979-7314-4C58-9D65-09716309221BQ43257603-2EA47971-8A7B-4242-8B8C-BC62D54CB936Q50087921-D631E525-0065-4F55-B1BE-AE397FCCFF15Q53788442-3E25875C-40AF-46FA-9D49-79E89115A661Q54301219-4611C14C-75D5-4137-9565-A6AB0BC7BB1B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The role of transporters in drug interactions.
@ast
The role of transporters in drug interactions.
@en
type
label
The role of transporters in drug interactions.
@ast
The role of transporters in drug interactions.
@en
prefLabel
The role of transporters in drug interactions.
@ast
The role of transporters in drug interactions.
@en
P2093
P1476
The role of transporters in drug interactions.
@en
P2093
Christopher J Endres
Francisco S Chung
Jashvant D Unadkat
Peng Hsiao
P304
P356
10.1016/J.EJPS.2005.11.002
P407
P577
2005-12-20T00:00:00Z